Drutz David 4
4 · Altimmune, Inc. · Filed Aug 15, 2023
Insider Transaction Report
Form 4
Drutz David
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2023-08-15$2.88/sh+300$863→ 29,785 total(indirect: See Footnote)
Footnotes (2)
- [F1]Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC.
- [F2]Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.